Allergy Diagnostics Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 5.70 Billion |
| Market Size (2029) | USD 9.80 Billion |
| CAGR (2024 - 2029) | 11.45 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Allergy Skin Test Market Analysis
The Allergy Diagnostics Market size is estimated at USD 5.70 billion in 2024, and is expected to reach USD 9.80 billion by 2029, growing at a CAGR of 11.45% during the forecast period (2024-2029).
The allergic diagnostics market experienced significant setbacks during the pandemic, primarily because many clinics offering these tests had to temporarily close due to lockdowns. For example, a January 2022 article in Clinical and Translational Allergy highlighted the pandemic's repercussions on medical professionals treating allergic patients. This included challenges in diagnostics, management, and treatment techniques, notably allergen immunotherapy (AIT) for food, insect venom, and respiratory allergies. Furthermore, most allergy and immunology care was either postponed, delayed, or managed through virtual consultations.
Patients with severe asthma had limited opportunities for in-person consultations, restricted to critical situations. These challenges during the pandemic have hindered market growth. Yet, with the easing of pandemic restrictions, the market is poised for significant growth in the coming years, driven by rising allergy cases and swift technological advancements in allergy diagnostics.
Market growth is being fueled by rising allergic disease incidences and environmental pollution. Conditions like hives, atopic dermatitis, allergic conjunctivitis, and various food allergies are on the rise, bolstering market expansion. For instance, data from the CDC in January 2023 revealed that in 2021, nearly 33% of U.S. adults and over 25% of children reported seasonal allergies, eczema, or food allergies. Specifically, about 6% had food allergies, with Black, non-Hispanic individuals being notably affected. Additionally, 25.7% of adults experienced seasonal allergies, 7.3% had eczema, and 6.2% faced food allergies. Such high prevalence rates are set to boost the demand for allergy diagnostics, propelling market growth.
Moreover, companies are increasingly channeling efforts into research and development, crafting innovative diagnostic products, tests, and kits to address significant unmet medical needs. For instance, in May 2022, Amulet, known for its cutting-edge molecular detection technology, unveiled two brands: 'Allergy Amulet', a wearable alerting users to food allergens, and 'Amulet Scientific', a platform for detecting various molecular targets, from food toxins to environmental contaminants.
In a similar vein, Scottish tech startup LiberEat, based in Aberdeen, garnered USD 0.26 million (GBP 209 thousand) in grant funding from Innovate UK in October 2022. This funding aims to expedite the development of their allergen platform and enhance its machine learning capabilities. Such advancements underscore a strong commitment to meeting both consumer and industry demands for superior allergen detection and safety.
Given the rising prevalence of allergies and increased investments in allergy detection products, the market is set for substantial growth. However, challenges like limited awareness of allergic diseases and the affordability of diagnostic tests could temper this growth trajectory.
Allergy Skin Test Market Trends
Inhaled Allergens Segment Expects to Register a High CAGR in the Allergy Diagnostics Market Over the Forecast Period
Inhaled allergies, the most prevalent type of allergy, can be triggered by various airborne pollutants found both indoors and outdoors. Seasonal inhalant allergies, commonly referred to as hay fever, are especially widespread. Outdoor allergens typically include pollen, mold spores, fungi, dust, and other irritants. In contrast, indoor allergens consist of animal dander, dust mites, fragrances, and more.
The inhaled allergens segment is set to witness significant growth in the allergy diagnostics market during the forecast period. This anticipated surge is driven by factors such as rising environmental pollution, a global uptick in respiratory allergies and asthma cases, and an increased demand for allergy testing. For instance, 2022 data from the National Health Service revealed that around 1.17 million individuals in England were diagnosed with chronic obstructive pulmonary disorder (COPD) during the 2020-2021 period, representing 1.9% of the population. Given this rising burden of allergic and respiratory conditions, there's an escalating demand for allergy diagnostic tests that identify sensitivities to a wide array of inhaled allergens.
Furthermore, rapid urbanization, industrialization, and subsequent lifestyle changes have led many countries to witness a sharp uptick in air pollutants. This surge has been linked to an increase in allergies, including asthma and allergic rhinitis. For example, the World Air Quality Report by IQAir in March 2022 highlighted India's position as the fifth most polluted nation out of 117 globally assessed regions. In 2021, India's annual average PM2.5 levels were recorded at 58.1 micrograms per cubic meter (µg/m3). As airborne allergens continue to escalate, the demand for early diagnosis and treatment is expected to rise, subsequently boosting the market for diagnostic tests and systems that pinpoint allergy-causing pollutants.
Climate change, driving a surge in allergic diseases, is a pivotal factor propelling the inhaled allergens segment of the allergy diagnostics market. An April 2024 article in Frontiers in Science underscores the ramifications of climate change, noting its role in amplifying pollen burdens, wildfires, and dust storms. Such environmental shifts are modifying human exposures and triggering intricate immune responses, leading to a rise in allergic conditions like asthma and rhinitis. Consequently, there's a heightened demand for precise diagnosis and monitoring of these environmental allergies, emphasizing the need for tests covering a broad spectrum of inhaled allergens. This trend is set to bolster the demand for allergy diagnostic tests.
Moreover, the strategic maneuvers of prominent market players are anticipated to further bolster the demand for allergy diagnostic devices. A case in point: Oncologica's June 2022 introduction of "Allergyfocus," a cutting-edge antibody allergy test. This test boasts a rapid and precise detection rate for 99% of common global allergies, offering a tailored antibody profile for each patient.
In conclusion, the inhaled allergens segment stands on the brink of significant expansion in the allergy diagnostics market. This growth is fueled by escalating environmental pollution, a global rise in respiratory allergies and asthma, an urgent need for comprehensive allergy testing, and proactive measures from industry leaders.
North America is Anticipated to Hold a Significant Market Share Over the Forecast Period
North America is set to witness significant growth in the allergy diagnostics market. This surge is driven by several factors: the increasing incidence of allergic diseases, environmental pollution, rising healthcare expenditures, and intensified activities by companies in the sector.
Chronic respiratory diseases, notably chronic obstructive pulmonary disease (COPD), remain a pressing public health issue in the U.S. According to a June 2024 update from the U.S. Centers for Disease Control and Prevention, COPD ranks among the top 10 causes of death, impacting nearly 16 million adults, with many undiagnosed. Characterized by restricted airflow and breathing challenges, COPD's prevalence underscores the broader impact of respiratory ailments on the populace. Given the absence of a cure for COPD, effective management becomes paramount. This often means tackling environmental factors and allergies that can worsen the condition. As such, the rising prevalence of COPD and similar respiratory issues drives the demand for comprehensive allergy diagnostics. Tests that pinpoint sensitivity to inhaled allergens are particularly sought after, as both healthcare providers and patients aim to navigate the intricate relationship between environmental factors, immune responses, and chronic lung diseases.
Furthermore, heightened company activities and a wave of product approvals in the region are set to bolster market growth in the coming years. For instance, in August 2022, the U.S. FDA greenlit Thermo Fisher’s ImmunoCAP Specific IgE (sIgE) Allergen Components for wheat and sesame allergies. This in vitro diagnostic tool aids healthcare professionals in pinpointing these allergies in susceptible patients.
In a similar vein, in October 2024, ALK unveiled its new branded allergy skin testing devices, including the AllerTest-1, AllerTest-8, and AllerTest-10, all approved by the U.S. FDA. These devices boast enhanced ergonomics, precision, and patient comfort. Additionally, the AllerTest 48-well and 60-well trays come with an air-tight locking mechanism to prevent contamination. Such a diverse range of allergy testing solutions not only meets the varied demands of healthcare professionals and patients but also boosts market competitiveness, aiming to capture a larger share of the burgeoning demand for precise and user-friendly allergy diagnostics. These approvals can significantly influence the allergy diagnostics market by fostering product differentiation.
As the allergy diagnostics market evolves, it's propelled by technological advancements and innovative solutions addressing the rising burden of respiratory ailments. For example, in September 2022, RxCap, Inc. and ZEPHYRx LLC joined forces to merge their remote monitoring platforms. This integration allows for lung function monitoring in patients with severe pulmonary conditions, benefiting RxCap's enterprise clients, including providers and payers. Such collaborations can enhance disease management, broaden market outreach, offer data-driven insights, and foster a more unified ecosystem in the allergy diagnostics arena, ultimately serving patients with respiratory challenges better.
In conclusion, the interplay of rising allergy-related diseases and proactive measures by industry leaders suggests a robust growth trajectory for the North American allergy diagnostics market in the foreseeable future.
Allergy Skin Test Industry Overview
The allergy diagnostics market is moderately fragmented and consists of several market players. The key market players are involved in various strategic activities such as partnerships, product launches, and agreements, which are further expected to bolster the market growth. The presence of major market players, such as BioMerieux SA, Thermo Fischer Scientific Inc, Omega Diagnostics, Siemens Healthineers AG, and Danaher Corporation, intensifies the market competition.
Allergy Skin Test Market Leaders
-
BioMerieux SA
-
Siemens Healthineers AG
-
Thermo Fischer Scientific Inc
-
Omega Diagnostics Group PLC
-
Danaher Corporation
*Disclaimer: Major Players sorted in no particular order
Allergy Skin Test Market News
- December 2022: Proteomtech secured approval from South Korea's Ministry of Food and Drug Safety for their innovative diagnostic tool, 'Protea Allergy-Q 128M'. This kit, with 128 test lines on a single panel, allows simultaneous screening for 118 types of allergens, covering a broad spectrum of allergy-causing substances. Notably, it assesses atopy, respiratory issues, and food allergies concurrently.
- June 2022: Oncologica, a prominent healthcare testing laboratory in Cambridge, introduced the allergy focus test. This test aids individuals in identifying their body's reactions to common global allergens, offering insights into potential allergen triggers.
Allergy Diagnostics Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidences of Allergic Diseases
4.2.2 Environmental Pollution
4.3 Market Restraints
4.3.1 Lack of Awareness About Allergic Diseases
4.3.2 Affordability of Allergy Diagnostics
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value in USD)
5.1 By Allergen
5.1.1 Inhaled Allergens
5.1.2 Food Allergens
5.1.3 Other Allergens
5.2 By Product
5.2.1 Instruments
5.2.2 Consumables
5.2.3 Luminometers
5.3 By End-User
5.3.1 Diagnostic Laboratories
5.3.2 Hospitals
5.3.3 Other End-Users
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 BioMerieux SA
6.1.2 Danaher Corporation
6.1.3 Abionic SA
6.1.4 HOB Biotech Group Corp. Ltd
6.1.5 HYCOR Biomedical
6.1.6 Lincoln Diagnostics Inc.
6.1.7 Omega Diagnostics Group Plc
6.1.8 Siemens Healthineers AG
6.1.9 Stallergenes Greer Ltd
6.1.10 Thermo Fischer Scientific Inc
6.1.11 Revvity Inc. (PerkinElmer Inc.)
6.1.12 R-Biopharm AG
6.1.13 Immunodiagnostic Systems Holdings PLC (IDS)
6.1.14 Biomeric, Inc.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Allergy Skin Test Industry Segmentation
Allergy diagnostics are processes performed in clinical conditions in which a harmless external agent is suspected to have a pathological effect on a human being, thus causing discomfort. The diagnostic procedure for allergies depends on the type of allergens and the mode of transmission.
The allergy diagnostics market is segmented by allergens (inhaled allergens, food allergens, and other allergens), products (instruments, consumables, and luminometers), end users (diagnostic laboratories, hospitals, other end users), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally.
The report offers the value (in USD) for the above segments.
| By Allergen | |
| Inhaled Allergens | |
| Food Allergens | |
| Other Allergens |
| By Product | |
| Instruments | |
| Consumables | |
| Luminometers |
| By End-User | |
| Diagnostic Laboratories | |
| Hospitals | |
| Other End-Users |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Allergy Diagnostics Market Research Faqs
How big is the Allergy Diagnostics Market?
The Allergy Diagnostics Market size is expected to reach USD 5.70 billion in 2024 and grow at a CAGR of 11.45% to reach USD 9.80 billion by 2029.
What is the current Allergy Diagnostics Market size?
In 2024, the Allergy Diagnostics Market size is expected to reach USD 5.70 billion.
Who are the key players in Allergy Diagnostics Market?
BioMerieux SA, Siemens Healthineers AG, Thermo Fischer Scientific Inc, Omega Diagnostics Group PLC and Danaher Corporation are the major companies operating in the Allergy Diagnostics Market.
Which is the fastest growing region in Allergy Diagnostics Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Allergy Diagnostics Market?
In 2024, the North America accounts for the largest market share in Allergy Diagnostics Market.
What years does this Allergy Diagnostics Market cover, and what was the market size in 2023?
In 2023, the Allergy Diagnostics Market size was estimated at USD 5.05 billion. The report covers the Allergy Diagnostics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Allergy Diagnostics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Allergy Diagnostics Industry Report
The Allergy Diagnostics and Therapeutics Market analysis provides comprehensive insights into the market growth, segmented by allergens such as inhaled allergens, food allergens, and other allergens. The report also covers products including instruments, consumables, and luminometers, and end-users such as diagnostic laboratories, hospitals, and other end-users. The market is further segmented by geography, including North America, Europe, Asia-Pacific, Middle East, and Africa, and South America.
The industry report highlights the market size and offers a detailed industry analysis, providing an industry overview and market forecast. The market report includes market trends and market data, offering a thorough market review and market outlook. The report also includes industry information, industry research, and industry statistics, which are crucial for understanding the market segmentation and market value.
This industry research includes a market forecast outlook and industry outlook, providing insights into market predictions and market growth. The report also features industry sales and industry size, offering a comprehensive view of the market leaders and market segmentation. The market analysis includes a report example and a report PDF for further reference.
The report summary emphasizes the importance of research companies in providing accurate market data and industry trends. The market forecast and market growth are essential components of the market overview, offering a detailed understanding of the market dynamics. The market review and market outlook provide valuable insights into the future market trends and industry statistics.
In conclusion, this industry report is a valuable resource for understanding the Allergy Diagnostics and Therapeutics Market, offering a comprehensive analysis of market trends, market leaders, and market predictions. The report provides a detailed market segmentation and market value, making it an essential tool for industry professionals and research companies.
